EPENDYMOMA, NOT OTHERWISE SPECIFIED (NOS)

Clinical trials for EPENDYMOMA, NOT OTHERWISE SPECIFIED (NOS) explained in plain language.

Never miss a new study

Get alerted when new EPENDYMOMA, NOT OTHERWISE SPECIFIED (NOS) trials appear

Sign up with your email to follow new studies for EPENDYMOMA, NOT OTHERWISE SPECIFIED (NOS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for kids with aggressive brain cancer: early trial tests novel immune therapy

Disease control Ongoing

This early-stage study is testing a new antibody drug called APX005M in children and young adults with brain tumors that have come back or are not responding to treatment, or with a newly diagnosed aggressive brain stem glioma. The main goal is to find the safest dose and underst…

Matched conditions: EPENDYMOMA, NOT OTHERWISE SPECIFIED (NOS)

Phase: PHASE1 • Sponsor: Pediatric Brain Tumor Consortium • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

EPENDYMOMA, NOT OTHERWISE SPECIFIED (NOS)

Get alerted when new EPENDYMOMA, NOT OTHERWISE SPECIFIED (NOS) trials appear

New hope for kids with aggressive brain cancer: early trial tests novel immune therapy